IL17A and systemic sclerosis: Although its precise role in SSc is unclear, preclinical studies indicate a potential role for IL-17 in regulating dermal and cardiac fibroblast proliferation, [95,96] and altered IL-17 expression has been reported in cells from patients with SSc [97].